Excerpt
Last month, my co-author and I published a book on the history of drug pricing in recognition that an inability to pay for medicines is growing into a public health emergency, with the potential to be every bit as dangerous as the current pandemic. Nearly 40% of respondents claimed to have skipped medicines due to solely to cost. Public opinion in the US seems to be reaching a tipping point, where it seems likely that government intervention will be necessary to guarantee access to vital medicines.